Variability of raltegravir plasma levels in the clinical setting.
about
The pharmacological challenges of treating tuberculosis and HIV coinfections.Effect of faldaprevir on raltegravir pharmacokinetics in healthy volunteers.Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse EventsImpact of UGT1A1 polymorphisms on Raltegravir and its glucuronide plasma concentrations in a cohort of HIV-1 infected patients.
P2860
Variability of raltegravir plasma levels in the clinical setting.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Variability of raltegravir plasma levels in the clinical setting.
@en
Variability of raltegravir plasma levels in the clinical setting.
@nl
type
label
Variability of raltegravir plasma levels in the clinical setting.
@en
Variability of raltegravir plasma levels in the clinical setting.
@nl
prefLabel
Variability of raltegravir plasma levels in the clinical setting.
@en
Variability of raltegravir plasma levels in the clinical setting.
@nl
P2093
P2860
P50
P356
P1433
P1476
Variability of raltegravir plasma levels in the clinical setting.
@en
P2093
Enzo Ragazzoni
Serena Fortuna
Simona Digiambenedetto
P2860
P356
10.1159/000351851
P577
2013-07-25T00:00:00Z